Pancreatic polypeptide: A marker for lean non-insulin-dependent diabetes mellitus?

F. J. Service, M. B. Koch, J. M. Jay, R. A. Rizza, V. L. Go

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Both basal and postprandial pancreatic polypeptide (PP) concentrations were exaggerated twofold in lean NIDDM patients, whereas they were normal in lean IDDM and obese NIDDM patients who were hyperglycemic as a result of partial insulin withdrawal. Insulin infusion from an artifical endocrine pancreas, which resulted in fasting euglycemia and near-normoglycemia postprandially, had no effect on PP responses in any of the diabetic patients. No postprandial PP responses were observed in totally pancreatectomized (TPX) patients. Excessive basal and postprandial concentrations of PP in diabetes appear to be related to both leanness and residual beta cell function and, therefore, potential markers for lean NIDDM.

Original languageEnglish (US)
Pages (from-to)349-353
Number of pages5
JournalDiabetes care
Issue number4
StatePublished - 1985

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing


Dive into the research topics of 'Pancreatic polypeptide: A marker for lean non-insulin-dependent diabetes mellitus?'. Together they form a unique fingerprint.

Cite this